Pyxis Oncology (PYXS) Revenue (2024 - 2025)
Pyxis Oncology (PYXS) reported Revenue of $11.0 million for Q4 2025, up 291.42% quarter-over-quarter from $2.8 million in Q2 2025.
Pyxis Oncology (PYXS) Revenue (2024 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 2 years of Revenue data on file, last reported at $11.0 million in Q4 2025.
- Revenue for Q4 2025 came in at $11.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $13.9 million (down 14.17% YoY), and the FY2025 annual result was $13.9 million, down 14.17% from the prior year.
- Revenue rose to $11.0 million in Q4 2025 per PYXS's latest filing, from $2.8 million in the prior quarter.
- Over five years, Revenue peaked at $16.1 million in Q1 2024 and troughed at $2.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Pyxis Oncology | 125.84 Mn | 108.95 Mn | 8.65 Mn | 11.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.04 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Mar 31, 2024 | 16.15 Mn |